Pfizer's the Way to Go in the Drug Sector

What's the best drug stock to own? Some value investors think it's Merck (MRK Quote), while well-known contrarians including Scudder's David Dreman favor Bristol-Myers (BMY Quote).

But I would argue they're both wrong. Because pound for pound, I think the answer is Pfizer (PFE Quote).

Just take a look at its drug portfolio and pipeline and you'll see what I mean. It sports four multibillion-dollar products that have the potential to post double-digit growth over the next year: Lipitor (for cholesterol), Norvasc (hypertension), Zoloft (depression) and Neurontin (epilepsy). In addition, it has several early stage drugs including Rebif (multiple sclerosis) and lasofoxifene (osteoporosis) that some folks -- including Salomon Smith Barney analyst George Grofik -- think could tag on another half a billion in sales each over the next few years. ...